HIITing Anxiety and Depression in Parkinson’s Disease and Multiple Sclerosis—A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT)
Authors:
- Arianne S. GravesteijnAGArianne S. Gravesteijn
- Marc B. RietbergMRMarc B. Rietberg
- Vincent de GrootVGVincent de Groot
- Mark A. HirschMHMark A. Hirsch
- Tim VanbellingenTVTim Vanbellingen
- Richard T. JaspersRJRichard T. Jaspers
- Chris VriendCVChris Vriend
- Wilma D. J. van de BergWBWilma D. J. van de Berg
- Odile A. van Den HeuvelOHOdile A. van Den Heuvel
- Erwin E. H. van WegenEWErwin E. H. van Wegen
- on behalf of the HersenFIT ConsortiumOCon behalf of the HersenFIT Consortium
Open Access
- 29 August 2025
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 15 (9) , 945
Abstract
Background/Objectives: Parkinson’s disease (PD) and multiple sclerosis (MS) are neurological conditions that result in debilitating non-motor symptoms, such as anxiety and depression, which significantly reduce quality of life and often persist despite pharmacological treatment. As a result, effective alternative treatment strategies are needed. Exercise therapy—particularly aerobic training—has shown promise in alleviating non-motor symptoms, potentially through neuroplastic adaptations. However, traditional aerobic exercise is often time-consuming and monotonous, limiting long-term adherence. High-intensity interval training (HIIT) offers a time-efficient and potentially more engaging alternative, though its effects on non-motor symptoms in PD and MS remain understudied. Methods: This transdiagnostic randomized controlled trial will enroll 48 participants (24 PD, 24 MS) with clinically significant affective symptoms (hospital anxiety and depression scale [HADS] ≥ 8). The participants will be randomly assigned to one of three 8-week interventions: (1) HIIT, 5–6 intervals of 45 s of high-intensity cycling; (2) continuous aerobic training (CAT), 50 min of low-intensity cycling; (3) movement advice (MA), step goals, and physical education. The primary (affective symptoms) and secondary outcomes (cognition, fatigue, sleep, motor function) will be assessed at four time points: 4 and 1 weeks pre intervention, and 1 and 4 weeks post intervention. Weekly blood samples and pre/post brain imaging will be collected to study biofluid and MRI measures for potential neuroplasticity. Linear mixed models will analyze the time and group effects. Discussion: This trial will assess whether HIIT can more effectively improve non-motor and motor symptoms in PD and MS than CAT or MA. A multimodal approach will explore both the clinical outcomes and underlying mechanisms, informing scalable and engaging rehabilitation strategies.Keywords
Funding Information
- Dutch Brain Foundation (DR-2019-00311)
This publication has 93 references indexed in Scilit:
- Exercise intensity matters: A review on evaluating the effects of aerobic exercise intensity on muscle‐derived neuroprotective myokinesAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2025
- Neurodegeneration in multiple sclerosisWIREs Mechanisms of Disease, 2022
- Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled TrialAnnals of Neurology, 2022
- Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trialsJournal of Neurology, 2019
- Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysisMovement Disorders, 2016
- The longitudinal impact of depression on disability in Parkinson diseaseInternational Journal of Geriatric Psychiatry, 2015
- Physical activity, exercise, depression and anxiety disordersJournal of Neural Transmission, 2008
- A systematic review of prevalence studies of depression in Parkinson's diseaseMovement Disorders, 2008
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's diseaseMovement Disorders, 2004
- A critical review of visual analogue scales in the measurement of clinical phenomenaResearch in Nursing & Health, 1990